The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4.

Factors influencing the morbidity and mortality associated with viremic hepatitis C virus (HCV) infection change over time and place, making it difficult to compare reported estimates. Models were developed for 17 countries (Bahrain, Bulgaria, Cameroon, Colombia, Croatia, Dominican Republic, Ethiopia, Ghana, Hong Kong, Jordan, Kazakhstan, Malaysia, Morocco, Nigeria, Qatar and Taiwan) to quantify and characterize the viremic population as well as forecast the changes in the infected population and the corresponding disease burden from 2015 to 2030. Model inputs were agreed upon through expert consensus, and a standardized methodology was followed to allow for comparison across countries. The viremic prevalence is expected to remain constant or decline in all but four countries (Ethiopia, Ghana, Jordan and Oman); however, HCV-related morbidity and mortality will increase in all countries except Qatar and Taiwan. In Qatar, the high-treatment rate will contribute to a reduction in total cases and HCV-related morbidity by 2030. In the remaining countries, however, the current treatment paradigm will be insufficient to achieve large reductions in HCV-related morbidity and mortality.

Estudio de la sensibilidad a los antimicrobianos de patógenos periodontales / Study of antimicrobial susceptibility of periodontal pathogens

Considerando que las diversas fallas en la implementación de la terapia antimicrobiana para el tratamiento de las periodontitis conducen a la aparición de cepas resistentes a los mismos, el objetivo de este trabajo fue realizar un estudio preliminar del patrón de resistencia a los antimicrobianos de uso común en la clínica de cepas de Porphyromonas gingivalis, Prevotella intermedia y Fusobacterium nucleatum. La prueba de sensibilidad a los antimicrobianos se realizó por el método de dilución en agar descrito por la NCCLS (National Committee for Clinical Laboratory Standards). Se probaron antimicrobianos seleccionados entre los más utilizados en la práctica clínica en nuestro medio: amoxicilina, clindamicina, doxiciclina, eritromicina, metronidazol y tetraciclina. Los resultados mostraron que el 100 por ciento de las cepas de P. gingivalisfueron resistentes a metronidazol y sensibles a tetraciclina, y un 33 por ciento sensibles a clindamicina. Las CIMs obtenidas para amoxicilina estuvieron entre 1 y 32 mg/ml, para doxiciclina entre 0,125 y 5 mg/ml y para eritromicina entre 8 y >32 mg/ml. En el caso de P. intermedia, se observó también un 100 por ciento de resistencia a metronidazol, un 67 por ciento de sensibilidad a tetraciclina y un 62,5 por ciento a clindamicina. Las CIMs para amoxicilina estuvieron entre 0,125 y 16 mg/ml, para doxicilina entre 0,125 y 4 mg/ml, y para eritromicina entre 8 y > 32 mg/ml. El 100 por ciento de las cepas de F. nucleatum resultaron sensibles a tetraciclina y resistentes a metronidazol, y el 25 por ciento fueron sensibles a clindamicina. En cuanto a amoxicilina, las CIMs estuvieron entre 0,125 y 16 mg/ml, para doxicilina entre 0,125 y 4 mg/ml, y eritromicina entre 16 y >32 mg/ml. Los patrones de resistencia obtenidos con estas cepas mostraron en general mayores porcentajes de resistencia que lo reportado por otros autores, lo que podría deberse a la falta de políticas de control en el uso de antimicrobianos en nuestro país...

Taking into account that several failures in antibiotic treatments used in periodontitis are driving to the appearance of resistant strains, the aim of this work was to realize a preliminary study of the resistance pattern to commonly used antimicrobials of regional Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum strains. Antibiotic susceptibility test was performed by NCCLS (National Committee for Clinical Laboratory Standards) agar dilution method. Proof antibiotics were selected among the most used in the clinical practice in our region: amoxicillin, clindamycin, doxycycline, erythromycin, metronidazole and tetracycline. The results showed that 100 percent of P.gingivalis strains were resistant to metronidazole and susceptible to tetracycline, and 33 percent susceptible to clindamycin. The MICs obtained for amoxicillin were between 1 and 32 mg/ml, for doxycycline between 0,125 and 5 mg/ml and for erythromycin between 8 and >32 mg/ml. In the case of P. intermedia, were also observed a 100 percent of resistance to metronidazole, 67 percent of susceptibility to tetracycline, and 62,5 percent of susceptibility to clindamycin.. The MICs for amoxicillin were between 0,125 y 16 mg/ml, for doxycycline between 0,125 and 4 mg/ml, and for erythromycin between 8 and >32 mg/ml. 100 percent of F. nucleatum strains were susceptible to tetracycline and resistant to metronidazole, and a 25 percent susceptible to clindamycin. MICs to amoxicillin were between 0,125 y 16 mg/ml, for doxycycline between 0,125 and 4 mg/ml, and to erythromycin between 16 and >32 mg/ml. Resistance patterns obtained with strains of our region showed higher percentages of resistance than those reported by other authors, which might owe to the lack of control politicise for the use of antimicrobials in our country. However, MICs values founded for the 50 and 90 percent of strains are similar to tose reported by NCCLS, except in the case of doxycycline, ...

[Cushing syndrome by ectopic ACTH secretion: analysis of the physiopathologic mechanism of hypokalemia. Report of two cases]. / Síndrome de Cushing por secreción ectópica de ACTH: análisis del mecanismo fisiopatológico de la hipokalemia. Comunicación de dos casos.

We report a 42 years old male and a 66 years old female with a Cushing syndrome caused by ectopic ACTH secretion secondary to a carcinoid tumor. These patients had both severe hypokalemia, resistant to medical treatment and that subsided with bilateral adrenalectomy and supplementation with dexametasone. Cushing syndrome caused by ectopic ACTH secretion is characterized by a severe and rapidly evolving hypercortisolism. Hypokalemia is present in 90% of cases and is probably caused by a defect in 11 beta hydroxysteroid dehydrogenase, that limits the binding of cortisol to aldosterone receptor, metabolizing it to cortisone. Therefore, this alteration will increase the mineralocorticoid action of cortisol.